Search for: "ACTAVIS" Results 701 - 720 of 1,006
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2015, 1:44 am
 *****  PREVIOUSLY, ON NEVER TOO LATE  Never too late 32 [week ending Sunday 8 February] –- Brazilian PTO’s delays | The Research Handbook on International Intellectual Property reviewed | Laura Smith-Hewitt | IP, women and leadership: the poll responses | Decline of West’s trust in innovation | Wikipedia public domain photos |CJEU in Case C-383/12 P Environmental Manufacturing LLP v OHIM | The Nordic IP Forum |… [read post]
20 Jul 2023, 1:42 am by Rose Hughes
 The Court of Appeal in Sandoz v BMS attempts to reconcile the Enlarged Board of Appeal (EBA) decision in G 2/21, and the landmark UK Supreme Court decision on plausibility Warner-Lambert v Actavis [2018] UKSC 56. [read post]
2 Feb 2015, 2:20 am
 Not only did the Dutch Court disagree with the Courts of England and Wales on the matter of priority entitlement and hence validity , but also this ruling appears to be in contrast to the case last week [for which see Katpost here for the first instance and here and here for the appeal judgment] where Arnold J permitted Actavis to launch a product with a skinny label without requiring further measures such as… [read post]
25 Jan 2017, 11:25 pm
In referring the question on Art 3(a) as to what was required for a product to be protected by a basic patent, he stated that he was “encouraged by what the [CJEU] said in Actavis v Sanofi and Actavis v Boehringer to believe that there is a realistic prospect of the Court providing further and better guidance to that which it has hitherto provided” (para 91). [read post]
7 Mar 2022, 12:44 am by Rose Hughes
However, as noted in the Finnish decision, CJEU case law has not yet harmonised interpretation of Article 3(a) under Royalty Pharma and its previous interpretations of Article 3(c), as in Actavis I (C-443/12) and Actavis II (C-577/13) (IPKat).The referralThe Supreme Court of Ireland referred 4 questions to the CJEU, the full text of which are provided in full below* ([2022] IESC 11). [read post]
12 Mar 2020, 1:48 am by Sophie Corke
Katherine Moggridge presenting Katherine Moggridge(Three New Square), who acted on behalf of appellants ICOS, discussed Actavis v ICOS, the most recent case in the UK Supreme Court to address obviousness. [read post]
31 Jul 2018, 7:58 am by Thorsten Bausch
In the decision leading to the referral, Justice Arnold considered that the answers previously given by the CJEU on the interpretation of Article 3 (a) in Medeva, Actavis v Sanofi and Lilly were not sufficiently clear and therefore asked question 1 in Actavis v Sanofi again: “What are the criteria for deciding whether ‘the product is protected by a basic patent in force’ in Article 3(a) of the SPC Regulation? [read post]
9 Dec 2010, 1:10 pm by Christa Culver
Mensing (Granted )Docket: 09-1039Issue(s): Whether the Eighth Circuit abrogated the Hatch-Waxman Amendments by allowing state tort liability for failure to warn in direct contravention of the Act’s requirement that a generic drug’s labeling be the same as the labeling approved by the Food and Drug Administration for the listed (or branded) drug.Certiorari-Stage Documents:Opinion below (8th Circuit)Petition for certiorariBrief in oppositionPetitioner's supplemental briefAmicus brief… [read post]
12 Feb 2014, 7:51 am by Dan Harris
The world’s second largest pharmaceutical company, Actavis, just did. [read post]
8 Jul 2014, 7:53 am by Barry Barnett
He pointed to the latest ruling, in Actavis, as cabining “patent triumphalism” in antitrust. [read post]
24 May 2010, 7:46 am by Erin Miller
Mensing; Actavis Elizabeth v. [read post]
7 Jan 2019, 6:21 am by Kluwer Patent blogger
’ Equivalents Number 10 on the list is the article Actavis and Equivalents – One Year On. [read post]
21 Jun 2013, 12:56 pm by Tejinder Singh
Actavis, the Court held, in a five-to-three decision by Justice Breyer (Justice Alito was recused), that antitrust lawsuits challenging so-called “reverse payments” may proceed. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets Purdue Pharma… [read post]
13 Apr 2015, 12:50 pm
| Oprah Winfrey and OWN YOUR POWER trade mark | EPO December Administrative Council Meeting | Blurred Lines | Again on Actavis v Boehringer | Is the EU Patent Package diminishing the EU’s powers? [read post]
17 Sep 2016, 4:56 am
| Judgement in Actavis v ICOS | Collective management of copyright for images displayed by search engines | Corporates and #Rio2016 | Global branding [read post]
22 Jun 2018, 3:18 am
Actavis |  Can YouTube be primarily liable for users' infringements? [read post]
25 May 2015, 1:28 am
In this respect this Kat has pondered whether Mr Justice Arnold’s decision Warner -Lambert Company, LLC v Actavis Group Ptc EHF & Others [2015] EWHC 72 (Pat) is a good one in respect of the interpretation of Swiss style claims (Katpost here). [read post]
27 Jul 2015, 9:35 am
| The IPKat and his friends | GO Outdoors Ltd v Skechers USA Inc II | Allfiled UK Ltd v Eltis & 16 Others | OAEE 'victims' mark in Greece | Icons, flags and the Hazzards of intellectual property toxicity | Why Finland is not Silicon Valley | The Sofa Workshop Ltd v Sofaworks Ltd | The Ukulele Orchestra of Great Britain v Clausen & Another (t/a the United Kingdom Ukulele Orchestra) | Sony/ATV Music Publishing LLC & Another v WPMC Ltd… [read post]
14 Mar 2016, 3:23 am
Never too late 83 [week ending on Sunday 14 February] – Indigenous IP | Arnold J's latest judgment flags down the iconic London black cab | Life of a national/EU trade mark ... in a map | A comprehensive explanation of trademarks | Actavis v Lilly. [read post]